Wallenstam AB (publ) (LON:0R7Y)
43.95
-0.50 (-1.12%)
At close: Oct 30, 2025
Wallenstam AB Revenue
Wallenstam AB had revenue of 791.00M SEK in the quarter ending September 30, 2025, with 18.41% growth. This brings the company's revenue in the last twelve months to 3.06B, down -7.56% year-over-year. In the year 2024, Wallenstam AB had annual revenue of 2.84B, down -15.27%.
Revenue (ttm)
3.06B SEK
Revenue Growth
-7.56%
P/S Ratio
9.38
Revenue / Employee
11.81M SEK
Employees
259
Market Cap
2.26B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.84B | -511.00M | -15.27% |
| Dec 31, 2023 | 3.35B | 781.00M | 30.44% |
| Dec 31, 2022 | 2.57B | 175.00M | 7.32% |
| Dec 31, 2021 | 2.39B | -276.00M | -10.35% |
| Dec 31, 2020 | 2.67B | 322.00M | 13.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |